Graphical summary. Credit score: The Journal of Molecular Diagnostics (2025). DOI: 10.1016/j.jmoldx.2025.01.003
Researchers have demonstrated the potential of the modern optical genome mapping (OGM) method for the prognosis, prognosis, and therapeutic administration of a number of myeloma. This new research in The Journal of Molecular Diagnostics, particulars how this novel methodology can set up the cytogenomic profile of the tumor on a scale appropriate for routine follow in cytogenetics laboratories.
A number of myeloma, a sort of blood most cancers that kinds in plasma cells (a sort of white blood cells), is the second most typical hematologic malignancy. Over the previous few a long time, the introduction of novel therapies has considerably improved progression-free survival and total survival, with much less toxicity and an improved high quality of life. However, the illness stays largely incurable with poor outcomes, particularly amongst sufferers immune to a number of drug lessons.
Cytogenetic gold commonplace workflow in a number of myeloma first begins with the isolation of tumor cells, which is an important prerequisite, adopted by conventional routine strategies (fluorescent in situ hybridization, “FISH”). Nonetheless, cell sorting usually limits the variety of markers that may be investigated resulting from low cell yields. Regardless that another strategies resembling excessive throughput DNA sequencing require fewer cells, the seek for markers stays focused and never exhaustive.
This research presents an modern method combining the cutting-edge OGM method, able to figuring out structural variants and replica quantity variations throughout the complete genome on a single take a look at with the combination of tumor and non-tumor fraction for every affected person to beat the problem of low cell quantity after cell sorting.
Lead investigator Agnès Daudignon, Ph.D., Institute of Medical Genetics, Lille College Hospital, and Hematology and Immunology Laboratory, Valenciennes College Hospital (France), explains, “We wanted to test the feasibility of OGM in the genetic management of multiple myeloma to establish the cytogenomic profile of the tumor on a scale suitable for routine practice in cytogenetics laboratories.”
Identification of t(11;14) IGH::CCND1 and outline of genetic lesions of Affected person 12. Credit score: The Journal of Molecular Diagnostics (2025). DOI: 10.1016/j.jmoldx.2025.01.003
Investigators examined the OGM method and confirmed the potential for decreasing the variety of cells required. They demonstrated that the method might be utilized to pure sorted samples diluted as much as 50% for full detection of clonal structural variants and replica quantity variants, with a detection threshold of a minimum of 20% for copy quantity variants at 50%.
Evaluation of a small sequence of sufferers confirmed a 93% concordance with the reference FISH method on 5 examined markers and allowed the identification of greater than 22 extra genomic variations of curiosity. This methodology streamlines a number of analyses right into a single take a look at, reduces materials necessities, and improves prognostic stratification for sufferers with a number of myeloma.
The pan-genomic nature of this know-how, mixed with the idea of blending tumor and non-tumor cells, makes this analysis significantly modern. It permits for the visualization of all rearrangements and numerical anomalies of the samples in a single layer, offering native laboratories and/or routine hospital settings with a wonderful stage of detection of a number of myeloma markers, which could possibly be described as pan-genomic know-how on a human scale.
Dr. Daudignon concludes, “After all, this know-how doesn’t enable for the detection of level mutations in genes, since it isn’t a sequencing method. Nonetheless, we have now demonstrated that focused complementary analysis for mutations on sure genes of curiosity might be carried out utilizing the identical DNA pattern extracted for the OGM, which means there isn’t a want to gather a brand new pattern from the affected person.
“Our research shows that integrating OGM into laboratory workflows would enhance prognostic stratification and expand therapeutic options.”
Extra data:
Hélène Guermouche et al, Deciphering Genomic Complexity of A number of Myeloma Utilizing Optimized Optical Genome Mapping, The Journal of Molecular Diagnostics (2025). DOI: 10.1016/j.jmoldx.2025.01.003
Quotation:
Optical genome mapping know-how exhibits promise for prognosis, prognosis and therapeutic choices of a number of myeloma (2025, April 14)
retrieved 14 April 2025
from https://medicalxpress.com/information/2025-04-optical-genome-technology-diagnosis-prognosis.html
This doc is topic to copyright. Aside from any honest dealing for the aim of personal research or analysis, no
half could also be reproduced with out the written permission. The content material is offered for data functions solely.
